Decent news but again at the horrific expense of s

Decent news but again at the horrific expense of shareholders. One thing to note. ESS trials, contrary to what many had suggested, are not fully funded by the Army. The release states that part of the proceeds will be used towards the ESS trial. Just read the release and you'll see it written. And again, no mention of when the trial will start. So more delays. And now, what about funding for the future? The company can't continue this negligent financial path for ever.